Serological, histological, and HLA typing of the unrelated HBV positive chronically infected individuals
| Subject No | HLA-A | HLA-B | HBV serology | ALT (iu/l) | HBV DNA | Liver biopsy |
| 1 | 2, 3 | 7, 44 | HBsAg/anti-HBe pos | 57 | Neg | Chronic active hepatitis |
| 2 | 2, 24 | 7, 51 | HBsAg/anti-HBe pos | 87 | Neg | Chronic active hepatitis |
| 3 | 2, 30 | 7, 18 | HBsAg/anti-HBe pos | 21 | Neg | nd |
| 4 | 1, 2 | 7, 13 | HBsAg/HBeAg pos | 230 | 1680 pg/ml | Chronic active hepatitis |
| 5 | 2, 11 | 35, 61 | HBsAg/anti-HBe pos | 15 | Neg | nd |
| 6 | 2, 28 | 35, 51 | HBsAg/anti-HBe pos | 67 | Neg | Inactive cirrhosis |
| 7 | 2, 3 | 18, 51 | HBsAg/anti-HBe pos | 28 | Neg | Mild hepatitis |
Serum alanine transaminase (ALT, normal range 5–40 iu/l) and serum hepatitis B virus (HBV) DNA measurements (branched chain DNA assay; Chiron Corporation, Emeryville, California, USA) are shown. Liver biopsy findings are shown where performed (nd indicates liver biopsy not performed).
HBV, hepatitis B virus; HBe, hepatitis B e; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; pos, positive; Neg, negative.